These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38840491)

  • 1. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study.
    Ooi H; Asai Y; Koriyama Y; Takahashi M
    Ann Pharmacother; 2024 Jun; ():10600280241255837. PubMed ID: 38840491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ceftriaxone Dosage and Albumin-Bilirubin Score on the Risk of Ceftriaxone-Induced Liver Injury.
    Ooi H; Asai Y; Koriyama Y; Takahashi M
    Biol Pharm Bull; 2023; 46(12):1731-1736. PubMed ID: 38044131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk evaluation of ampicillin/sulbactam-induced liver injury based on albumin-bilirubin score.
    Ooi H; Asai Y; Sato Y
    J Infect Chemother; 2023 Sep; 29(9):900-904. PubMed ID: 37301371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
    Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
    J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Teicoplanin-Associated Acute Kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin.
    Morinaga Y; Tanaka R; Tatsuta R; Takano K; Hashimoto T; Ogata M; Hiramatsu K; Itoh H
    Biol Pharm Bull; 2024; 47(5):988-996. PubMed ID: 38763761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
    Iwai N; Nakamura H; Miyazu M
    Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A six-month intraperitoneal repeated dose toxicity study of tazobactam/piperacillin and tazobactam in rats].
    Hayashi T; Yada H; Auletta CS; Daly IW; Knezevich AL; Cockrell BY
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():155-76. PubMed ID: 7830285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
    Oizumi K; Kawahara M; Kawaguchi S; Sigematsu H; Tanaka F; Sano N; Saito A; Hiraga Y; Ohmichi M; Inoue H
    Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
    Sato T; Lochry EA; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():215-32. PubMed ID: 7830288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study.
    Oda K; Hashiguchi Y; Katanoda T; Nakata H; Jono H; Saito H
    Microbiol Spectr; 2021 Sep; 9(1):e0035521. PubMed ID: 34346742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Takemoto M; Matsuo K; Oguro M; Kouchi Y
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():249-62. PubMed ID: 7830290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
    Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
    Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam(1)--Fertility and general reproduction study in rats with intraperitoneal administration].
    Sato T; Lochry EA; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():199-24. PubMed ID: 7830287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (3)--Perinatal and postnatal study in rats with intraperitoneal administration].
    Sato T; Hoberman AM; Christian MS
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():233-47. PubMed ID: 7830289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study.
    Kadomura S; Takekuma Y; Sato Y; Sumi M; Kawamoto K; Itoh T; Sugawara M
    J Pharm Health Care Sci; 2019; 5():13. PubMed ID: 31210955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
    Kuno K; Ogawa A; Hayakawa F; Miyajima Y; Takahashi H; Okumura A; Kato T; Itomi K
    Jpn J Antibiot; 1998 Jun; 51(6):395-406. PubMed ID: 9755829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
    Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
    Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Ohuchida A; Taniguti A; Kouchi Y; Maeda Y; Kashihara A; Omae S
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():263-80. PubMed ID: 7830291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.